Cargando…
Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as Nanocarrier
The current prognosis for glioblastoma is dismal. Treatment-resistant glioblastoma stem cells (GSCs) and the failure of most drugs to reach therapeutic levels within the tumor remain formidable obstacles to successful treatment. Chalcones are aromatic ketones demonstrated to reduce malignant propert...
Autores principales: | Veliz, Eduardo A., Kaplina, Anastasiia, Hettiarachchi, Sajini D., Yoham, Athina L., Matta, Carolina, Safar, Sabrin, Sankaran, Meghana, Abadi, Esther L., Cilingir, Emel Kirbas, Vallejo, Frederic A., Walters, Winston M., Vanni, Steven, Leblanc, Roger M., Graham, Regina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316063/ https://www.ncbi.nlm.nih.gov/pubmed/35890360 http://dx.doi.org/10.3390/pharmaceutics14071465 |
Ejemplares similares
-
Novel Curcumin Inspired Bis-Chalcone Promotes Endoplasmic Reticulum Stress and Glioblastoma Neurosphere Cell Death
por: Sansalone, Lorenzo, et al.
Publicado: (2019) -
In vivo characterization of carbon dots–bone interactions: toward the development of bone-specific nanocarriers for drug delivery
por: DuMez, Rachel, et al.
Publicado: (2021) -
Dual targeting nano-approaches for Alzheimer's disease etiology
por: Hettiarachchi, Sajini D., et al.
Publicado: (2020) -
Crossing the blood–brain barrier with carbon dots: uptake mechanism and in vivo cargo delivery
por: Seven, Elif S., et al.
Publicado: (2021) -
Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions
por: Vallejo, Frederic A., et al.
Publicado: (2023)